Biotechnology
Application of biological systems and organisms to develop products and technologies
Market Overview
Current Market Size
$850B (2024)
Projected Market Size
$1.2T (2030) (2024-2030)
Description
Synthetic biology, gene editing, biomanufacturing, precision medicine
Key Technology Segments
Synthetic Biology
Engineering biological systems for new functions
Gene Editing
CRISPR and other gene editing technologies
Biomanufacturing
Production of materials and chemicals using biological processes
Key Players
MIT
universityPioneering synthetic biology and gene editing research
Investment Trends
Investment in biotechnology has shown strong growth, with total funding reaching $42.1B in 2024.
Commercialization Pathways
Licensing
high feasibilityBiotech innovations often licensed to pharma companies for development and commercialization.
Spinout
high feasibilityStrong biotech startup ecosystem with significant investor interest and clear regulatory pathways.
Partnership
high feasibilityStrategic partnerships with pharma and biotech companies are common for early-stage technologies.
Regulatory Considerations
- •FDA approval processes
- •Clinical trial requirements
- •Biosafety regulations
- •Intellectual property protection
Leading Universities
MIT
75 spinouts • $45.2M revenue
Stanford
95 spinouts • $82.5M revenue
UC Berkeley
68 spinouts • $52.3M revenue
Harvard
38 spinouts • $42.5M revenue
Johns Hopkins
68 spinouts • $42.5M revenue
Related Tools
Get Market Intelligence
Use Commercify to analyze market opportunities and build your commercialization strategy.
Request Commercialization Playbook